Xeris Biopharma Holdings Inc (XERS)
Stock-Based Compensation
$28.12M
TTM · Period ending: · USD
XERS Stock-Based Compensation
Latest reported$28.12Mperiod ending
Latest reported$28.12Mperiod ending
XERS TTM Stock-Based Comp ($499.00K → $28.12M)
TTM stock-based compensation
High-resolution chart · PNG
XERS stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 28,121,000 | |
| 22,063,000 | |
| 22,366,000 | |
| 20,689,000 | |
| 19,814,000 | |
| 19,039,000 | |
| 18,363,000 | |
| 17,535,000 | |
| 13,224,000 | |
| 11,919,000 | |
| 10,716,000 | |
| 10,715,000 | |
| 11,199,000 | |
| 11,423,000 | |
| 12,160,000 | |
| 12,137,000 | |
| 12,861,000 | |
| 12,221,000 | |
| 11,381,000 | |
| 10,778,000 | |
| 9,167,000 | |
| 8,726,000 | |
| 8,273,000 | |
| 7,975,000 | |
| 7,715,000 | |
| 7,345,000 | |
| 6,484,000 | |
| 5,221,000 | |
| 3,971,000 | |
| 2,631,000 | |
| 1,728,000 | |
| 1,297,000 | |
| 857,000 | |
| 585,000 | |
| 499,000 |